NCT06524193 RCT Face-to-face Group Voice Therapy vs Telepractice Group Voice Therapy for Muscle Tension Dysphonia
| NCT ID | NCT06524193 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Voice Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 168 participants |
| Start Date | 2024-06-25 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 168 participants in total. It began in 2024-06-25 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare face-to-face group voice therapy to telepractice group voice therapy for muscle tension dysphonia (MTD). The main questions it aims to answer are: * The effectiveness of telepractice voice therapy for MTD using a randomized controlled trial study design. * The effectiveness of telepractice group voice therapy using a randomized controlled trial study design. Participants will receive telepractice group voice therapy or face-to-face group voice therapy. Researchers will compare telepractice group voice therapy to face-to-face group voice therapy for patients with MTD to see if it has the same effectiveness.
Eligibility Criteria
Inclusion Criteria: * Above or equal to 18 years of age; * Diagnosis of primary MTD or secondary MTD where voice therapy is the primary mode of treatment, such as vocal fold nodules; * Chinese-speaking subjects only. Exclusion Criteria: * Dysphonia of neurogenic or psychogenic origin; * Secondary muscle tension dysphonia in which voice therapy is not the primary treatment modality, such as vocal polyp, vocal cyst, granuloma, papilloma; * Low computer literacy or without social or family support for telepractice; * Patients who are not capable of making own consent; * Patients who are receiving other modalities of treatment which is not part of this current study, such as traditional Chinese medicine.
Contact & Investigator
Thomas Law, PhD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT06524193 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Voice Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06524193 currently recruiting?
Yes, NCT06524193 is actively recruiting participants. Contact the research team at thomaslaw@cuhk.edu.hk for enrollment information.
Where is the NCT06524193 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06524193 clinical trial?
NCT06524193 is sponsored by Chinese University of Hong Kong. The principal investigator is Thomas Law, PhD at Chinese University of Hong Kong. The trial plans to enroll 168 participants.